New drugs and therapies that meet medical challenges and improve health outcomes have a far-reaching impact on the quality and longevity of human life. Biotechnology firms play a critical role in improving human health by successfully licensing their patented discoveries. The search for a prospective licensing partner is challenging, however: biotech companies need to share highly confidential documents in parallel with multiple prospective licensing partners ‒ some who may be competitors ‒ while ensuring that none of these proprietary documents are compromised during the process.
Key Challenges
- Proprietary IP and patient data must be shared, yet secure
- Large number of dispersed potential licensees need parallel access
- Traditional in-person disclosure is costly and time-consuming
- Changes / updates must be communicated immediately
- Data breaches could compromise IP and sensitive clinical trial information
-
0.40 MB
Keine Kommunikationsobjekte vorhanden.




